Incidence and risk factors for hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation

被引：0
|
作者：
Gomez Hernando, M. [1 ]
Pedraza, A. [1 ]
Quintana, L. [2 ]
Carcelero, E. [3 ]
Riu, G. [3 ]
Monge, I. [3 ]
Domenech, A. [1 ]
Solano, M. T. [1 ]
Suarez-Lledo, M. [1 ]
Martinez-Cibrian, N. [1 ]
Rosinol, L. [1 ]
Gutierrez-Garcia, G. [1 ]
Carreras, E. [4 ]
Esteve, J. [1 ]
Urbano-Ispizua, A. [1 ]
Fernandez Aviles, F. [1 ]
Martinez, C. [1 ]
Rovira, M. [1 ]
Salas, M. Q. [1 ]
机构：
[1] Hosp Clin Barcelona, Inst Hematol & Oncol, IDIBAPS, Barcelona, Spain
[2] Hosp Clin Barcelona, Inst Nephrol & Urol, IDIBAPS, Barcelona, Spain
[3] Hosp Clin Barcelona, Pharmacol Unit, IDIBAPS, Barcelona, Spain
[4] Fundacio Josep Carreras, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P173
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [1] Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation
    Gomez-Hernando, Marta
    Quintana, Luis F.
    Suarez-Lledo, Maria
    Martinez-Cibrian, Nuria
    Rivero, Andrea
    Ruiz-Boy, Sonia
    Carcelero, Ester
    Mate, Paula
    Riu, Gisela
    Monge, Ines
    Serrahima, Anna
    Solano, Maria Teresa
    Rosinol, Laura
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    Carreras, Enric
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    Salas, Maria Queralt
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (02) : 212 - 214
  • [2] Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation
    Marta Gómez-Hernando
    Luis F. Quintana
    María Suárez-Lledo
    Nuria Martínez-Cibrian
    Andrea Rivero
    Sonia Ruiz-Boy
    Ester Carcelero
    Paula Mate
    Gisela Riu
    Inés Monge
    Anna Serrahima
    Maria Teresa Solano
    Laura Rosiñol
    Jordi Esteve
    Alvaro Urbano-Ispizua
    Enric Carreras
    Francesc Fernández-Avilés
    Carmen Martínez
    Montserrat Rovira
    Maria Queralt Salas
    [J]. Bone Marrow Transplantation, 2023, 58 : 212 - 214
  • [3] Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
    Daniel J. Ikeda
    Zachariah DeFilipp
    Kerry Collier
    Yi-Bin Chen
    Bimalangshu R. Dey
    Areej El-Jawahri
    Matthew J. Frigault
    Mark B. Leick
    Steven L. McAfee
    Richard A. Newcomb
    Paul V. O’Donnell
    Thomas R. Spitzer
    [J]. Bone Marrow Transplantation, 2024, 59 (1) : 131 - 133
  • [4] Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
    Ikeda, Daniel J.
    DeFilipp, Zachariah
    Collier, Kerry
    Chen, Yi-Bin
    Dey, Bimalangshu R.
    El-Jawahri, Areej
    Frigault, Matthew J.
    Leick, Mark B.
    McAfee, Steven L.
    Newcomb, Richard A.
    O'Donnell, Paul V.
    Spitzer, Thomas R.
    [J]. BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 131 - 133
  • [5] Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
    Mohty, Razan
    Al Kadhimi, Zaid
    Kharfan-Dabaja, Mohamed
    [J]. HEMATOLOGY, 2024, 29 (01)
  • [6] Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
    Mata, Allogeneic - Adult Jonaphine Rae
    Zahurak, Marianna
    Rosen, Natalie
    Dezern, Amy E.
    Jones, Richard J.
    Ambinder, Alexander J.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (06): : 588 - 596
  • [7] Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Hebert, Courtney
    Watts, Nicole
    Isaac, Shiney
    Kukkamalla, Rivvi
    Jamy, Omer
    Saad, Ayman
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S276 - S277
  • [8] Allogeneic Hematopoietic Cell Transplantation for Lymphoma: Baseline and Post-Transplant Prognostic Factors
    Ko, Sun-Hye
    Lee, Jung-Hee
    Lee, Je-Hwan
    Park, Han-Seung
    Choi, Eun-Ji
    Lee, Young-Shin
    Kang, Young-Ah
    Lee, Kyoo-Hyung
    [J]. BLOOD, 2016, 128 (22)
  • [9] Validation of Different Prognostic Scores in Allogeneic Hematopoietic Cell Transplantation in the Post-Transplant Cyclophosphamide Era
    Salas, Maria Queralt
    Rodriguez-Lobato, Luis Gerardo
    Suarez-Lledo, Maria
    Martinez-Cibrian, Nuria
    Solano, Teresa
    Arcarons, Jordi
    Llobet, Noemi
    Domenech, Ariadna
    Pedraza, Alexandra
    Nomdedeu, Meritxell
    Cid, Joan
    Lozano, Miquel
    Rosinol, Laura
    Fernandez-Aviles, Francesc
    Gutierrez-Garcia, Gonzalo
    Carreras, Enric
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    Rovira, Montserrat
    Martinez, Carmen
    [J]. BLOOD, 2021, 138
  • [10] Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation
    Kinzel, Megan
    Dowhan, Michelle
    Kalra, Amit
    Williamson, Tyler S.
    Dabas, Rosy
    Jamani, Kareem
    Chaudhry, Ahsan
    Shafey, Mona
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Daly, Andrew
    Dharmani-Khan, Poonam
    Khan, Faisal
    Storek, Jan
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 53.e1 - 53.e10
12345